133 related articles for article (PubMed ID: 31785541)
1. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1.
Mura M; Bastaroli F; Corli M; Ginevrino M; Calabrò F; Boni M; Crotti L; Valente EM; Schwartz PJ; Gnecchi M
Stem Cell Res; 2020 Jan; 42():101658. PubMed ID: 31785541
[TBL] [Abstract][Full Text] [Related]
2. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1.
Mura M; Ginevrino M; Zappatore R; Pisano F; Boni M; Castelletti S; Crotti L; Valente EM; Schwartz PJ; Gnecchi M
Stem Cell Res; 2018 May; 29():170-173. PubMed ID: 29684900
[TBL] [Abstract][Full Text] [Related]
3. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation.
Mura M; Lee YK; Pisano F; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Tse HF; Gnecchi M
Stem Cell Res; 2019 May; 37():101437. PubMed ID: 31009818
[TBL] [Abstract][Full Text] [Related]
4. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation.
Mura M; Lee YK; Pisano F; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Tse HF; Gnecchi M
Stem Cell Res; 2019 May; 37():101431. PubMed ID: 30974404
[TBL] [Abstract][Full Text] [Related]
5. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene.
Mura M; Lee YK; Ginevrino M; Zappatore R; Pisano F; Boni M; Dagradi F; Crotti L; Valente EM; Schwartz PJ; Tse HF; Gnecchi M
Stem Cell Res; 2018 May; 29():157-161. PubMed ID: 29677589
[TBL] [Abstract][Full Text] [Related]
6. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene.
Mura M; Pisano F; Stefanello M; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Brink PA; Gnecchi M
Stem Cell Res; 2019 Apr; 36():101416. PubMed ID: 30878014
[TBL] [Abstract][Full Text] [Related]
7. Generation of induced pluripotent stem cell lines from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene.
Ren L; Jahng JWS; Belbachir N; Cook Z; Rivero GC; Perez MV; Wu JC
Stem Cell Res; 2024 Aug; 78():103443. PubMed ID: 38763038
[TBL] [Abstract][Full Text] [Related]
8. Generation of eight human induced pluripotent stem cell (iPSC) lines from familial Long QT Syndrome type 1 (LQT1) patients carrying KCNQ1 c.1697C>A mutation (NUIGi005-A, NUIGi005-B, NUIGi005-C, NUIGi006-A, NUIGi006-B, NUIGi006-C, NUIGi007-A, and NUIGi007-B).
Ge N; Liu M; Krawczyk J; McInerney V; Galvin J; Shen S; O'Brien T; Prendiville T
Stem Cell Res; 2019 Aug; 39():101502. PubMed ID: 31415974
[TBL] [Abstract][Full Text] [Related]
9. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.
Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M
Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a human induced pluripotent stem cell line, KSCBi015-A, from a long QT syndrome type 1 patient harboring a KCNQ1 mutation.
Lee Y; Park H; Kyung Koo S; Kim JH
Stem Cell Res; 2021 Oct; 56():102521. PubMed ID: 34509919
[TBL] [Abstract][Full Text] [Related]
11. Generation of human induced pluripotent stem cell line from a patient with a long QT syndrome type 2.
Fatima A; Ivanyuk D; Herms S; Heilmann-Heimbach S; O'Shea O; Chapman C; Izsvák Z; Farr M; Hescheler J; Šarić T
Stem Cell Res; 2016 Mar; 16(2):304-7. PubMed ID: 27345990
[TBL] [Abstract][Full Text] [Related]
12. Generation of patient-specific induced pluripotent stem cell lines from one patient with Jervell and Lange-Nielsen syndrome, one with type 1 long QT syndrome and two healthy relatives.
Kasai-Brunswick TH; Silva Dos Santos D; Ferreira RP; Araujo DS; Dias GM; Coutinho JLA; Cruz FESF; Sternick EB; Gubert F; Oliveira JCG; Vaz IM; Borgonovo T; Brofman PRS; Moura-Neto RS; Silva R; Campos-de-Carvalho AC; Carvalho AB
Stem Cell Res; 2018 Aug; 31():174-180. PubMed ID: 30099333
[TBL] [Abstract][Full Text] [Related]
13. Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population.
Mura M; Pisano F; Stefanello M; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Brink PA; Gnecchi M
Stem Cell Res; 2019 Aug; 39():101510. PubMed ID: 31398660
[TBL] [Abstract][Full Text] [Related]
14. Generation and characterization of the human induced pluripotent stem cell (hiPSC) line NCUFi001-A from a patient carrying KCNQ1 G314S mutation.
Lavra L; Magi F; Ulivieri A; Morgante A; Paulis M; Sala L; Pedrazzini M; Polisca P; Rocchetti M; Calò L; Sciacchitano S; Salehi LB
Stem Cell Res; 2021 Jul; 54():102418. PubMed ID: 34130155
[TBL] [Abstract][Full Text] [Related]
15. Large-Scale Simulation of the Phenotypical Variability Induced by Loss-of-Function Long QT Mutations in Human Induced Pluripotent Stem Cell Cardiomyocytes.
Paci M; Casini S; Bellin M; Hyttinen J; Severi S
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428582
[TBL] [Abstract][Full Text] [Related]
16. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
17. Generation of a human iPSC line (MPIi008-A) from a patient with Denys-Drash syndrome.
Doeser MC; Krygin J; Röpke A; Han D; Wedlich-Söldner R; Schöler HR; Pavenstädt H; Kim KP
Stem Cell Res; 2022 Jul; 62():102826. PubMed ID: 35667217
[TBL] [Abstract][Full Text] [Related]
18. mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.
Grace HE; Galdun P; Lesnefsky EJ; West FD; Iyer S
Stem Cells Dev; 2019 Jul; 28(13):846-859. PubMed ID: 31017045
[TBL] [Abstract][Full Text] [Related]
19. Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation.
Zhang X; Moon SY; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
Stem Cell Res; 2019 May; 37():101452. PubMed ID: 31059986
[TBL] [Abstract][Full Text] [Related]
20. An induced pluripotent stem cell line (SHEHi002-A (5426))from a patient of long QT syndrome type 8 with c.2573G>A mutation in the gene CACNA1C.
Zhou HM; Zhou XQ; Lu JZ; Jia WW; Kang JH
Stem Cell Res; 2020 Mar; 43():101731. PubMed ID: 32062134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
